AstraZeneca vaccine is 79% effective against symptomatic Covid-19, company says
Video Credit: WXYZ Detroit - Duration: 03:23s - Published
AstraZeneca vaccine is 79% effective against symptomatic Covid-19, company says
AstraZeneca has announced the results from its long-awaited US-based clinical trial, saying that its COVID-19 vaccine is safe and provides strong protection against symptomatic infection.
The Pfizer COVID-19 vaccine has been found to be 100% effective in adolescents, who showed “very high antibody” responses, exceeding the antibody responses in vaccinated adults, the company..
The European Union's Internal Market Commissioner Thierry Breton said on Friday that vaccines produced by AstraZeneca within the bloc will stay there until the company returns to fulfilling its..